CVE-2024-10476: Becton Dickinson & Co Bd Bactec Blood Culture System

High severity, CVSS 8.0. EPSS: 0.2% chance of exploitation in the next 30 days.

Default credentials are used in the above listed BD Diagnostic Solutions products. If exploited, threat actors may be able to access, modify or delete data, including sensitive information such as protected health information (PHI) and personally identifiable information (PII). Exploitation of this vulnerability may allow an attacker to shut down or otherwise impact the availability of the system. Note: BD Synapsys™ Informatics Solution is only in scope of this vulnerability when installed on a NUC server. BD Synapsys™ Informatics Solution installed on a customer-provided virtual machine or on the BD Kiestra™ SCU hardware is not in scope.

Affected products

• Becton Dickinson & Co Bd Bactec Blood Culture System: up to and including 7.20
• Becton Dickinson & Co Bd Cor System: up to and including 8.90
• Becton Dickinson & Co Bd Epicenter Microbiology Data Management System: up to and including 7.45
• Becton Dickinson & Co Bd Max System: up to and including 6.10
• Becton Dickinson & Co Bd Phoenix m50 Automated Microbiology System: up to and including 2.70
• Becton Dickinson & Co Bd Synapsys Informatics Solution: up to and including 6.10

Published 2024-12-17. Last modified 2026-06-17.